Notice Title

Consent to the Distribution of New Medicines

Publication Date
3 Jun 2021

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2021-go2140
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Trisul
Active Ingredients:

Sulfamethoxazole 400mg

Trimethoprim 80mg

Dosage Form: Tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturers:

Intas Pharmaceuticals Limited, Sanand, India

Alphapharm Pty Limited, Brisbane, Australia

   
Product: Zavicefta
Active Ingredients:

Avibactam sodium 543.5mg equivalent to avibactam 500mg

Ceftazidime pentahydrate 2329.7mg equivalent to ceftazidime 2000mg

Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: ACS Dobfar SpA, Verona, Italy


Dated this 31st day of May 2021.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).